Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
EUDA Health Holdings ( (EUDA) ) has provided an update.
EUDA Health Holdings has initiated preliminary discussions with Guangdong Cell Biotech to explore a joint venture aimed at advancing biotechnology innovation in Southeast Asia. This collaboration seeks to combine EUDA’s digital healthcare capabilities with Guangdong Cell Biotech’s expertise in stem cell therapies, potentially enhancing EUDA’s market presence and product offerings while fostering innovation in preventive healthcare solutions and regenerative medicine.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based health technology company that operates a unique digital healthcare ecosystem in Southeast Asia, focusing on affordable, accessible healthcare and improved patient outcomes through personalized care. The company’s AI platform aids in medical assessments, triage, and connecting patients with clinicians, supporting various stages of healthcare.
YTD Price Performance: 316.71%
Average Trading Volume: 72,328
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $221.4M
See more data about EUDA stock on TipRanks’ Stock Analysis page.
